Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Glucovance

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Aim Is to evaluate the influence of glucovance therapy on biomechanical properties of bone in streptozotocin - induced diabetes… Expand
2017
2017
  • 2017
  • Corpus ID: 42205869
Glyburide is an oral antihyperglycemic drug of the sulfonylurea class. The chemical name for glyburide is 1-[[p-[2-(5-chloro-o… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2015
2015
This study was attempted to formulate a combination product of Glyburide and Metformin Hydrochloride Tablets USP 2.5mg/500mg and… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
2010
2010
  • 2010
  • Corpus ID: 9248433
Glyburide is an oral antihyperglycemic drug of the sulfonylurea class. The chemical name for glyburide is 1-[[p-[2-(5-chloro-o… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2006
2006
This exploratory double‐blind, randomised, 20‐week study evaluated the mechanism of action of metformin–glibenclamide combination… Expand
Highly Cited
2003
Highly Cited
2003
OBJECTIVE An open-label, parallel-group, randomized, multicenter trial was conducted to compare efficacy and safety of… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Review
2003
Review
2003
  • A. Scheen
  • Revue medicale de Liege
  • 2003
  • Corpus ID: 24033659
Glucovance, recently launched by Merck-Lipha (Glucovance 500 mg/2.5 mg and Glucovance 500 mg/5 mg), is a fixed combined therapy… Expand
2002
2002
ObjectiveTo compare the effects of two different formulations of glibenclamide (glyburide) combined with metformin on… Expand
2001
2001
OBJECTIVE: This study is conducted to determine the economic impact of the addition of a new diabetic agent, Glucovance… Expand